The Venlafaxine Hydrochloride Tablet, cataloged under National Stock Number 6505-01-387-5060, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Teva Pharmaceuticals Usa, Inc.. Government technical data includes 1 specification, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-387-5060 |
| Primary Part Number | NDC00093-9148-01 |
| Item Name | Venlafaxine Hydrochloride Tablet |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Teva Pharmaceuticals Usa, Inc. |
| Status | ACTIVE |
| General Characteristics Item Description | 37.5 MG ACTIVE INGREDIENT; 100 TABLETS |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00093-9148-01 PRIMARY | Teva Pharmaceuticals Usa, Inc. (USA) |
| NDC57664-0393-88 PRIMARY | Sun Pharmaceutical Industries, Inc. (USA) |
| Reference | Meaning |
|---|---|
| NDC00378-4882-01 | 5/9 Secondary reference Mylan Pharmaceuticals Inc |
NSN 6505-01-387-5060 is a Venlafaxine Hydrochloride Tablet, manufactured by Teva Pharmaceuticals Usa, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-387-5060 has 2 manufacturer part numbers on file: NDC00093-9148-01 (Teva Pharmaceuticals Usa, Inc.), NDC57664-0393-88 (Sun Pharmaceutical Industries, Inc.).
Key specifications for NDC00093-9148-01: General Characteristics Item Description: 37.5 MG ACTIVE INGREDIENT; 100 TABLETS; Part Name Assigned by Controlling Agency: VENLAFAXINE HYDROCHLORIDE TABLETS,USP 37.5MG 100S BT. 1 specification is documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.